Haemonetics Corporation (HAE)
USD 63.85
(1.37%)
USD 63.85
(1.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 164.88 Million USD | 5.67% |
| 2023 | 156.03 Million USD | 93.23% |
| 2022 | 80.75 Million USD | 39.31% |
| 2021 | 57.96 Million USD | -62.35% |
| 2020 | 153.95 Million USD | 84.27% |
| 2019 | 83.54 Million USD | 48.77% |
| 2018 | 56.15 Million USD | 389.75% |
| 2017 | -19.38 Million USD | 55.94% |
| 2016 | -43.98 Million USD | -208.49% |
| 2015 | 40.54 Million USD | -14.34% |
| 2014 | 47.32 Million USD | -16.14% |
| 2013 | 56.43 Million USD | -36.41% |
| 2012 | 88.75 Million USD | -19.71% |
| 2011 | 110.54 Million USD | 32.74% |
| 2010 | 83.28 Million USD | -2.67% |
| 2009 | 85.56 Million USD | 21.74% |
| 2008 | 70.28 Million USD | 12.02% |
| 2007 | 62.74 Million USD | -36.63% |
| 2006 | 99.01 Million USD | 65.19% |
| 2005 | 59.94 Million USD | 30.66% |
| 2004 | 45.87 Million USD | 22.41% |
| 2003 | 37.47 Million USD | 2.83% |
| 2002 | 36.44 Million USD | 171.59% |
| 2001 | 13.42 Million USD | -60.1% |
| 2000 | 33.63 Million USD | 6.1% |
| 1999 | 31.7 Million USD | 2.26% |
| 1998 | 31 Million USD | -35.95% |
| 1997 | 48.4 Million USD | -10.87% |
| 1996 | 54.3 Million USD | 3.63% |
| 1995 | 52.4 Million USD | 1.16% |
| 1994 | 51.8 Million USD | 23.92% |
| 1993 | 41.8 Million USD | 39.8% |
| 1992 | 29.9 Million USD | -80.99% |
| 1991 | 157.3 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 35.3 Million USD | -34.21% |
| 2024 Q4 | 51.16 Million USD | 11.28% |
| 2024 Q3 | 45.97 Million USD | 30.24% |
| 2024 FY | 208.13 Million USD | 33.39% |
| 2024 Q1 | 53.65 Million USD | 52.2% |
| 2023 Q1 | 30.76 Million USD | 60.25% |
| 2023 Q2 | 46.73 Million USD | 51.89% |
| 2023 Q3 | 43.27 Million USD | -7.39% |
| 2023 Q4 | 35.25 Million USD | -18.54% |
| 2023 FY | 156.03 Million USD | 93.23% |
| 2022 Q4 | 19.19 Million USD | -46.15% |
| 2022 FY | 80.75 Million USD | 39.31% |
| 2022 Q2 | 24.51 Million USD | 1663.31% |
| 2022 Q3 | 35.65 Million USD | 45.45% |
| 2022 Q1 | 1.39 Million USD | 106.56% |
| 2021 Q3 | 40.42 Million USD | -31.23% |
| 2021 Q1 | 11.71 Million USD | -54.95% |
| 2021 Q2 | 58.78 Million USD | 401.77% |
| 2021 FY | 57.96 Million USD | -62.35% |
| 2021 Q4 | -21.17 Million USD | -152.38% |
| 2020 Q3 | 40.9 Million USD | -17.76% |
| 2020 Q2 | 49.73 Million USD | 473.92% |
| 2020 Q4 | 26 Million USD | -36.42% |
| 2020 FY | 153.95 Million USD | 84.27% |
| 2020 Q1 | -13.3 Million USD | -155.76% |
| 2019 Q2 | 26.07 Million USD | 392.65% |
| 2019 Q4 | 23.85 Million USD | -15.76% |
| 2019 Q3 | 28.32 Million USD | 8.61% |
| 2019 Q1 | 5.29 Million USD | -62.92% |
| 2019 FY | 83.54 Million USD | 48.77% |
| 2018 Q2 | 24.25 Million USD | 46.04% |
| 2018 FY | 56.15 Million USD | 389.75% |
| 2018 Q4 | 14.27 Million USD | 1309.18% |
| 2018 Q1 | 16.61 Million USD | 128.89% |
| 2018 Q3 | 1.01 Million USD | -95.82% |
| 2017 Q1 | -7.88 Million USD | -40.96% |
| 2017 FY | -19.38 Million USD | 55.94% |
| 2017 Q2 | 24.79 Million USD | 414.6% |
| 2017 Q4 | -57.5 Million USD | -371.1% |
| 2017 Q3 | 21.21 Million USD | -14.45% |
| 2016 Q3 | -61.17 Million USD | -418.98% |
| 2016 FY | -43.98 Million USD | -208.49% |
| 2016 Q1 | 3.6 Million USD | -68.75% |
| 2016 Q4 | -5.59 Million USD | 90.86% |
| 2016 Q2 | 19.17 Million USD | 431.86% |
| 2015 Q1 | -1.66 Million USD | -113.17% |
| 2015 Q4 | 11.53 Million USD | -36.81% |
| 2015 Q3 | 18.26 Million USD | 47.17% |
| 2015 FY | 40.54 Million USD | -14.34% |
| 2015 Q2 | 12.4 Million USD | 844.72% |
| 2014 Q1 | -6.6 Million USD | -137.32% |
| 2014 FY | 47.32 Million USD | -16.14% |
| 2014 Q3 | 17.86 Million USD | -23.77% |
| 2014 Q2 | 23.43 Million USD | 454.57% |
| 2014 Q4 | 12.64 Million USD | -29.19% |
| 2013 Q3 | 15.74 Million USD | 59.04% |
| 2013 Q2 | 9.9 Million USD | -24.3% |
| 2013 Q1 | 13.07 Million USD | -37.6% |
| 2013 FY | 56.43 Million USD | -36.41% |
| 2013 Q4 | 17.7 Million USD | 12.45% |
| 2012 Q2 | 18.56 Million USD | -22.34% |
| 2012 Q3 | 25.32 Million USD | 36.39% |
| 2012 Q4 | 20.96 Million USD | -17.23% |
| 2012 Q1 | 23.9 Million USD | -17.26% |
| 2012 FY | 88.75 Million USD | -19.71% |
| 2011 Q3 | 28.55 Million USD | -1.2% |
| 2011 Q1 | 24.18 Million USD | 490.41% |
| 2011 Q2 | 28.9 Million USD | 19.5% |
| 2011 FY | 110.54 Million USD | 32.74% |
| 2011 Q4 | 28.89 Million USD | 1.18% |
| 2010 Q2 | 27.02 Million USD | 2.64% |
| 2010 Q1 | 26.32 Million USD | 45.19% |
| 2010 FY | 83.28 Million USD | -2.67% |
| 2010 Q4 | 4.09 Million USD | -84.14% |
| 2010 Q3 | 25.83 Million USD | -4.4% |
| 2009 Q3 | 24.49 Million USD | 3.74% |
| 2009 Q2 | 23.6 Million USD | 22.11% |
| 2009 Q4 | 18.13 Million USD | -25.96% |
| 2009 Q1 | 19.33 Million USD | -4.74% |
| 2009 FY | 85.56 Million USD | 21.74% |
| 2008 FY | 70.28 Million USD | 12.02% |
| 2008 Q4 | 20.29 Million USD | 3.57% |
| 2008 Q3 | 19.59 Million USD | 34.08% |
| 2008 Q1 | 15.77 Million USD | -38.59% |
| 2008 Q2 | 14.61 Million USD | -7.37% |
| 2007 Q1 | 15.04 Million USD | -70.03% |
| 2007 FY | 62.74 Million USD | -36.63% |
| 2007 Q4 | 25.69 Million USD | 51.09% |
| 2007 Q3 | 17 Million USD | 229.81% |
| 2007 Q2 | 5.15 Million USD | -65.72% |
| 2006 Q2 | 15.37 Million USD | -16.85% |
| 2006 Q1 | 18.49 Million USD | 17.28% |
| 2006 FY | 99.01 Million USD | 65.19% |
| 2006 Q4 | 50.18 Million USD | 235.57% |
| 2006 Q3 | 14.95 Million USD | -2.75% |
| 2005 Q2 | 13.91 Million USD | -7.02% |
| 2005 FY | 59.94 Million USD | 30.66% |
| 2005 Q1 | 14.96 Million USD | 1.86% |
| 2005 Q3 | 15.3 Million USD | 9.98% |
| 2005 Q4 | 15.77 Million USD | 3.07% |
| 2004 FY | 45.87 Million USD | 22.41% |
| 2004 Q2 | 8.9 Million USD | 8.8% |
| 2004 Q4 | 14.68 Million USD | 4.21% |
| 2004 Q1 | 8.18 Million USD | 33.34% |
| 2004 Q3 | 14.09 Million USD | 58.28% |
| 2003 Q4 | 6.13 Million USD | -48.07% |
| 2003 FY | 37.47 Million USD | 2.83% |
| 2003 Q3 | 11.82 Million USD | 20.31% |
| 2003 Q2 | 9.82 Million USD | 1.38% |
| 2003 Q1 | 9.69 Million USD | -13.12% |
| 2002 FY | 36.44 Million USD | 171.59% |
| 2002 Q2 | 12.95 Million USD | -51.61% |
| 2002 Q1 | 26.77 Million USD | 288.2% |
| 2002 Q3 | 2.8 Million USD | -78.34% |
| 2002 Q4 | 11.15 Million USD | 297.58% |
| 2001 FY | 13.42 Million USD | -60.1% |
| 2001 Q1 | 8.32 Million USD | -7.82% |
| 2001 Q2 | 8.34 Million USD | 0.26% |
| 2001 Q3 | 10.96 Million USD | 31.36% |
| 2001 Q4 | -14.22 Million USD | -229.71% |
| 2000 Q3 | 8.9 Million USD | 21.92% |
| 2000 FY | 33.63 Million USD | 6.1% |
| 2000 Q4 | 9.03 Million USD | 1.49% |
| 2000 Q1 | 8.5 Million USD | -8.6% |
| 2000 Q2 | 7.3 Million USD | -14.12% |
| 1999 Q1 | 7.3 Million USD | -8.75% |
| 1999 FY | 31.7 Million USD | 2.26% |
| 1999 Q4 | 9.3 Million USD | 27.4% |
| 1999 Q3 | 7.3 Million USD | -8.75% |
| 1999 Q2 | 8 Million USD | 9.59% |
| 1998 Q4 | 8 Million USD | 8.11% |
| 1998 FY | 31 Million USD | -35.95% |
| 1998 Q1 | 9.6 Million USD | -11.93% |
| 1998 Q2 | 6.1 Million USD | -36.46% |
| 1998 Q3 | 7.4 Million USD | 21.31% |
| 1997 Q1 | 14.1 Million USD | 6.82% |
| 1997 Q4 | 10.9 Million USD | 4.81% |
| 1997 Q3 | 10.4 Million USD | -19.38% |
| 1997 Q2 | 12.9 Million USD | -8.51% |
| 1997 FY | 48.4 Million USD | -10.87% |
| 1996 Q2 | 13.7 Million USD | 1.48% |
| 1996 Q1 | 13.5 Million USD | 3.85% |
| 1996 Q3 | 13.9 Million USD | 1.46% |
| 1996 FY | 54.3 Million USD | 3.63% |
| 1996 Q4 | 13.2 Million USD | -5.04% |
| 1995 Q4 | 13 Million USD | 0.0% |
| 1995 Q1 | 12.7 Million USD | -9.29% |
| 1995 Q2 | 13.8 Million USD | 8.66% |
| 1995 Q3 | 13 Million USD | -5.8% |
| 1995 FY | 52.4 Million USD | 1.16% |
| 1994 Q2 | 13 Million USD | 17.12% |
| 1994 Q1 | 11.1 Million USD | -5.13% |
| 1994 FY | 51.8 Million USD | 23.92% |
| 1994 Q4 | 14 Million USD | 2.19% |
| 1994 Q3 | 13.7 Million USD | 5.38% |
| 1993 Q3 | 11.2 Million USD | 8.74% |
| 1993 Q4 | 11.7 Million USD | 4.46% |
| 1993 FY | 41.8 Million USD | 39.8% |
| 1993 Q1 | 8.8 Million USD | -3.3% |
| 1993 Q2 | 10.3 Million USD | 17.05% |
| 1992 Q3 | 7.7 Million USD | 10.0% |
| 1992 Q4 | 9.1 Million USD | 18.18% |
| 1992 Q2 | 7 Million USD | 16.67% |
| 1992 FY | 29.9 Million USD | -80.99% |
| 1992 Q1 | 6 Million USD | -84.77% |
| 1991 Q2 | 39.3 Million USD | 0.0% |
| 1991 Q1 | 39.3 Million USD | 0.0% |
| 1991 Q3 | 39.3 Million USD | 0.0% |
| 1991 Q4 | 39.4 Million USD | 0.25% |
| 1991 FY | 157.3 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alcon Inc. | 1.03 Billion USD | 84.131% |
| AptarGroup, Inc. | 404.01 Million USD | 59.189% |
| Baxter International Inc. | 390 Million USD | 57.722% |
| Becton, Dickinson and Company | 2.42 Billion USD | 93.201% |
| Bausch + Lomb Corporation | 130 Million USD | -26.833% |
| Envista Holdings Corp | 31.5 Million USD | -423.438% |
| ResMed Inc. | 1.31 Billion USD | 87.508% |
| Teleflex Incorporated | 506.31 Million USD | 67.435% |
| Warby Parker Inc. | -71.99 Million USD | 329.017% |
| West Pharmaceutical Services, Inc. | 676 Million USD | 75.609% |